Genomic Prediction
PrivateLast Round
Series A
Extension
Dec 15, 2021
Total Funding Raised
$16.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Genomic Prediction is a biotechnology company that provides advanced genomic tests which improve in-vitro fertilization (IVF) health outcomes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genomic Prediction Comparables
Compare Genomic Prediction with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Orchid Health | 93% | |
| Juno Genetics | 86% | |
| Progenesis | 85% | |
Genomic Prediction Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 15, 2021 | ||||
| Series A | Jan 31, 2019 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 19, 2026
Santiago Munné appointed as Chief Scientific Officer.
- Oct 23, 2025
Accused of trade secret misappropriation by Nucleus Genomics.
Genomic Prediction Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genomic Prediction's valuation, stock price, and market status.